Floatz logo

OTENABANT

Stroke

I.R.C.C.S. Fondazione Santa LuciaSmall moleculeN/AActive
D
28/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
65/ 100

Competitive context

140 Active assets in the Stroke cohort.

Asset / SponsorPhaseRating
Rivaroxaban
China National Center for Cardiovascular Diseases
Phase 4BBB
Tenecteplase
Assistance Publique - Hôpitaux de Paris
Phase 4BBB
Acetylsalicylic Acid
China National Center for Cardiovascular Diseases
Phase 4BB
Ticagrelor
Assistance Publique - Hôpitaux de Paris
Phase 4BB
WARFARIN
China National Center for Cardiovascular Diseases
Phase 4BB

View all 50 →

Same molecule, other indications

OTENABANT is also rated in:

obesity disorderDormant
B
Indicative ·
57 / 100
View asset →
Pain, NerveDormant
B
Indicative ·
57 / 100
View asset →
liver failureDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →